We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

VEDA LAB

VEDALAB focuses on the development, production and marketing of in vitro immunodiagnostic reagents and instruments. I... read more Featured Products: More products

Download Mobile App





Vedalab Exhibits Rapid Diagnostic Tests

By LabMedica International staff writers
Posted on 11 Nov 2024
Print article
Image: Vedalab is exhibiting at MEDICA 2024 at booth number n°1A64, Hall 1 (Photo courtesy of Vedalab)
Image: Vedalab is exhibiting at MEDICA 2024 at booth number n°1A64, Hall 1 (Photo courtesy of Vedalab)

Vedalab (Cerisé, France) is showcasing its wide range of rapid diagnostic tests at the MEDICA exhibition from November 11th to 14th, 2024 being held in Dusseldorf, Germany.

Vedalab offers a wide range of immunochromatographic rapid tests which are being highlighted at the trade fair. This includes the new Vitamin D-CHECK-1 immunochromatographic rapid test for the quantitative determination of Vitamin D in plasma or serum samples and the Toxo IgG-CHECK-1 immunochromatographic rapid test for the qualitative detection of IgG antibodies to Toxoplasma gondii in whole blood, plasma or serum samples. Vedalab’s quantitative rapid tests are designed for use on its EASY READER+ instrument showcased at MEDICA 2024. This POC reader enables quantitative measurements from finger-prick whole blood samples using rapid lateral flow tests. The instrument includes the most advanced and up-to-date technologies such as touch screen, enhanced memory, and internet upgrading. The EASY READER+ and quantitative rapid tests are designed for healthcare professionals, for use in physician’s offices, clinical laboratories, and online pharmacies, and for consumers through organizations that provide diagnostic information.

Vedalab’s EASY READER+ and quantitative rapid tests are widely used as screening tools for various medical conditions and diseases. Vedalab is also highlighting its range of immunochromatographic rapid tests for the quantitative detection of AFP (alpha-fetoprotein), beta chain specific hCG (human chorionic gonadotrophin), C-peptide, CA 125 (ovarian cancer antigen), Cancer Antigen 15-3 (CA 15-3), Cancer Antigen 19-9 (CA 19-9), Calprotectin, CEA (carcinoembryonic antigen), Creatine Kinase MB isoenzyme, Cortisol, C-reactive protein, and D-DIMER in whole blood, serum, urine or plasma samples. These tests generate accurate, rapid, and cost-effective diagnostic information for acute and chronic conditions affecting men's and women's health at various stages of life.

Related Links:
Vedalab

New
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Gold Member
ZIKA Virus Test
ZIKA ELISA IgG
New
Parasite Suspension for QC
Cryptosporidium Species Parasite Suspension
New
PAPP-A Test
PAPP-A Mass Units AccuBind ELISA

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Pathology

view channel
Image: Lunit SCOPE HER2 is an AI-powered solution designed to detect HER2 expression profile (Photo courtesy of Lunit)

AI-Powered Pathology Solutions Accurately Predict Outcomes for HER2-Targeted Therapy in Metastatic CRC

A new study has highlighted how artificial intelligence (AI)-powered analysis of HER2 and the tumor microenvironment (TME) can improve patient stratification and predict clinical outcomes more effectively.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.